You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CB1 Receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Spinal Cord Injuries Trial in Toledo (Rimonabant)

Not yet recruiting
  • Spinal Cord Injuries
  • Toledo, Spain
    Hospital Nacional de Paraplejicos
Nov 14, 2022

Diabete Type 2, Abdominal Obesity Trial in Dijon (Sampling of adipose tissue)

Recruiting
  • Diabete Type 2
  • Abdominal Obesity
  • Sampling of adipose tissue
  • Dijon, France
    Chu Dijon Bourgogne
Oct 5, 2021

Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

Active, not recruiting
  • Carcinoma, Ductal, Breast
  • +2 more
  • Sofia, Bulgaria
  • +7 more
Aug 1, 2022

Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)

Recruiting
  • Subarachnoid Hemorrhage
  • Plymouth, Devon, United Kingdom
  • +11 more
May 16, 2022

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Amyotrophic Lateral Sclerosis Trial in St. Gallen ([18F]-RoSMA-18-d6)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • St. Gallen, Switzerland
    Muskelzentrum/ALS-Clinic, Kantonsspital St. Gallen
May 19, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Acute Cannabinoid Intoxication Trial in Leiden (ANEB-001, Placebo)

Active, not recruiting
  • Acute Cannabinoid Intoxication
  • Leiden, ZH, Netherlands
    Centre for Human Drug Research (CHDR)
Jan 31, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • (no location specified)
Nov 9, 2023

Myeloma Trial in Houston (Fludarabine phosphate, Cyclophosphamide, NY-ESO-1 TCR/IL-15 NK)

Not yet recruiting
  • Myeloma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Leptin Receptor Deficiency Obesity Trial in Worldwide (setmelanotide, Placebo)

Completed
  • Leptin Receptor Deficiency Obesity
  • New York, New York
  • +6 more
Jan 26, 2021

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Obesity Associated With Defects in Leptin-melanocortin Pathway Trial in Worldwide (Setmelanotide)

Enrolling by invitation
  • Obesity Associated With Defects in Leptin-melanocortin Pathway
  • Chandler, Arizona
  • +31 more
Dec 6, 2022

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

MS Patients Treated With Sphingosine-1-phosphate Receptor

Recruiting
  • Multiple Sclerosis
  • S1PR analysis on immune cells
  • Bern, Switzerland
    Neurology department
Apr 12, 2023

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

Recruiting
  • Diabetes
  • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting
  • Digestive System Neuroendocrine Tumor G1
  • +5 more
  • Tumor Debulking
  • +5 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Aug 23, 2023

Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

Recruiting
  • Schizophrenia
  • +2 more
  • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
  • New Haven, Connecticut
    Connecticut Mental Health Center
Sep 16, 2022